N-メチルスコポラミン。メチルスコポラミン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/08/12 22:06:07」(JST)
[Wiki en表示]
Methylscopolamine bromide
|
Systematic (IUPAC) name |
(1R,2S,4R,5S,7R)-{[(2R)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane
|
Clinical data |
Trade names |
Pamine, Extendryl, AlleRx, Rescon |
AHFS/Drugs.com |
monograph |
MedlinePlus |
a606008 |
Pharmacokinetic data |
Biological half-life |
3–4 hrs |
Identifiers |
CAS Registry Number |
155-41-9 |
ATC code |
A03BB03 S01FA03 |
PubChem |
CID: 441342 |
DrugBank |
DB00462 Y |
ChemSpider |
21106347 Y |
UNII |
RTN51LK7WL Y |
ChEMBL |
CHEMBL376897 Y |
Chemical data |
Formula |
C18H24NO4 |
Molecular mass |
318.388 g/mol |
SMILES
-
OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3[N+](C)(C)[C@H](C2)[C@H]4O[C@@H]34
|
InChI
-
InChI=1S/C18H24NO4/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11/h3-7,12-17,20H,8-10H2,1-2H3/q+1/t12-,13-,14-,15+,16-,17+/m1/s1 Y
-
Key:LZCOQTDXKCNBEE-IKIFYQGPSA-N Y
|
Y (what is this?) (verify) |
Methylscopolamine or methscopolamine, usually provided as the bromide salt (trade name Pamine), is an oral medication used along with other medications to treat peptic ulcers by reducing stomach acid secretion.[1] Proton pump inhibitors and antihistamine medications have made this use obsolete. It can also be used for stomach or intestinal spasms, to reduce salivation, and to treat motion sickness. Methscopolamine is also commonly used as a drying agent, to dry up post-nasal drip, in cold, irritable bowel syndrome and allergy medications (trade names Extendryl, AlleRx, Rescon).
Methscopolamine, a methylated derivative of scopolamine, is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine. Its mechanism of action involves blocking the muscarinic acetylcholine receptors.
References
- ^ Drugs.com: Methscopolamine
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
Drugs for functional gastrointestinal disorders (A03)
|
|
Drugs for
functional
bowel disorders |
Antimuscarinics
|
Tertiary
amino group
|
- Oxyphencyclimine
- Camylofin
- Mebeverine
- Trimebutine
- Rociverine
- Dicycloverine
- Dihexyverine
- Difemerine
- Piperidolate
|
|
Quaternary
ammonium
compounds
|
- Benzilone
- Mepenzolate
- Pipenzolate
- Glycopyrronium
- Oxyphenonium
- Penthienate
- Methantheline
- Propantheline
- Otilonium
- Tridihexethyl
- Isopropamide
- Hexocyclium
- Poldine
- Bevonium
- Diphemanil
- Tiemonium
- Prifinium
- Timepidium
- Fenpiverinium
|
|
|
Phosphodiesterase
inhibitors
|
- Papaverine
- Drotaverine
- Moxaverine
|
|
Acting on
serotonin receptors
|
- 5-HT3 antagonists
- 5-HT4 agonists
- Mosapride
- Prucalopride
- Tegaserod
|
|
Other
|
- Alverine
- Caroverine
- Chlorbenzoxamine
- Diisopromine
- Dimethylaminopropionylphenothiazine
- Fenpiprane
- Fenoverine
- Idanpramine
- Isometheptene
- Phloroglucinol
- Pinaverium
- Proxazole
- Silicones
- Tiropramide
- Trepibutone
- Trimethyldiphenylpropylamine
|
|
|
Belladonna
and derivatives
(antimuscarinics) |
- tertiary amines: Atropine
- Hyoscyamine
- quaternary ammonium compounds:
- Scopolamine
- Butylscopolamine
- Methylscopolamine
- Methylatropine
- Fentonium
- Cimetropium bromide
|
|
Propulsives |
- primarily dopamine antagonists
- Metoclopramide/Bromopride
- Clebopride
- Domperidone
- Alizapride
- 5-HT4 agonists
|
|
Index of digestion
|
|
Description |
- Anatomy
- Physiology
- Development
|
|
Disease |
- Congenital
- Neoplasms and cancer
- Inflammatory bowel disease
- Gluten sensitivity
- Other
- Symptoms and signs
- Blood tests
|
|
Treatment |
- Procedures
- Drugs
- anabolic steroids
- antacids
- diarrhoea and infection
- bile and liver
- functional gastrointestinal disorders
- laxatives
- peptic ulcer and reflux
- nausea and vomiting
- other
- Surgery
|
|
|
English Journal
- M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
- Keller M1, Tränkle C2, She X3, Pegoli A3, Bernhardt G3, Buschauer A3, Read RW4.
- Bioorganic & medicinal chemistry.Bioorg Med Chem.2015 Jul 15;23(14):3970-90. doi: 10.1016/j.bmc.2015.01.015. Epub 2015 Jan 14.
- A series of new dibenzodiazepinone-type muscarinic receptor ligands, including two homo-dimeric compounds, was prepared. Sixteen representative compounds were characterized in equilibrium binding studies with [(3)H]N-methylscopolamine ([(3)H]NMS) at the muscarinic receptor subtype M2, and seven sele
- PMID 25650309
- 50 years ago in The Journal of Pediatrics: congenital pyloric stenosis: a controlled evaluation of medical treatment utilizing methyl-scopolamine-nitrate.
- Gisser JM1, Hill ID1.
- The Journal of pediatrics.J Pediatr.2015 Mar;166(3):593. doi: 10.1016/j.jpeds.2014.09.044.
- PMID 25722265
- Coupling of g proteins to reconstituted monomers and tetramers of the M2 muscarinic receptor.
- Redka DS1, Morizumi T2, Elmslie G3, Paranthaman P1, Shivnaraine RV1, Ellis J4, Ernst OP5, Wells JW6.
- The Journal of biological chemistry.J Biol Chem.2014 Aug 29;289(35):24347-65. doi: 10.1074/jbc.M114.559294. Epub 2014 Jul 14.
- G protein-coupled receptors can be reconstituted as monomers in nanodiscs and as tetramers in liposomes. When reconstituted with G proteins, both forms enable an allosteric interaction between agonists and guanylyl nucleotides. Both forms, therefore, are candidates for the complex that controls sign
- PMID 25023280
Japanese Journal
- Role of the third intracellular loop in the subtype-specific internalization and recycling of muscarinic M2 and M4 receptors
- YOSHIDA Norihiro,JOJIMA Eri,SAITO Hiroyuki,HAGA Tatsuya
- Biomedical Research 35(3), 185-192, 2014
- … Muscarinic M2, M4, and M2-M4 chimera receptors were transiently expressed in HEK-293tsA201 cells, and agonist-dependent internalization of these receptors and recycling of internalizedreceptors were examined by measuring the amount of cell-surface receptors as [3H]N-methylscopolamine(NMS) binding activity. …
- NAID 130004470866
- Assessment of Novel Muscarinic Acetylcholine Receptors in Rat Cerebral Cortex by a Tissue Segment Binding Method
- Lee Kung-Shing,Nishimune Atsushi,Yoshiki Hatsumi [他],ANISUZZAMAN Abu Syed Md,SUZUKI Fumiko,WANG Mao-Hsien,CHENG Juei-Tang,MURAMATSU Ikunobu
- Journal of pharmacological sciences 112(4), 444-451, 2010-04-20
- … These mAChRs were a mixture of high- and low-affinity sites for <I>N</I>-methylscopolamine (NMS) in a 70:30 ratio. …
- NAID 10027909139
- Pharmacologically Relevant Receptor Binding Characteristics and 5α-Reductase Inhibitory Activity of Free Fatty Acids Contained in Saw Palmetto Extract(Pharmacology)
- Abe Masayuki,Ito Yoshihiko,Oyunzul Luvsandorj [他],OKI-FUJINO Tomomi,YAMADA Shizuo
- Biological & pharmaceutical bulletin 32(4), 646-650, 2009-04-01
- … Also, lauric acid, oleic acid, myristic acid and linoleic acid inhibited specific [^3H]N-methylscopolamine ([^3H]NMS) binding in rat brain with IC_<50> …
- NAID 110007160688
Related Links
- The most updated news about prescription drugs, over the counter drugs, natural medications, side effects, drug interactions and warnings. ... Tell your doctor about all the medicines you take including prescription and non ...
- Drug Description methylscopolamine Possible antagonism of action (source: Drug Bank) methylscopolamine Possible antagonism of action (source: Drug Bank) methylscopolamine The therapeutic effects ...
Related Pictures
★リンクテーブル★
[★]
- 英
- N-methylscopolamine
- 化
- メチル硫酸N-メチルスコポラミン N-methylscopolamine methylsulfate
- 商
- ダイピン
- 関
- メチルスコポラミン、methylscopolamine
[★]
メチル硫酸N-メチルスコ・ラミン
- 関
- N-methylscopolamine
[★]
N-メチルスコポラミン